Mechanisms of immune checkpoint inhibitor-mediated liver injury
The immune checkpoints, cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death protein-1/ligand-1 (PD-1/PD-L1) are vital contributors to immune regulation and tolerance. Recently immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy; however, they come with t...
Saved in:
Main Authors: | Layla Shojaie (Author), Myra Ali (Author), Andrea Iorga (Author), Lily Dara (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy
by: Shike Lou, et al.
Published: (2024) -
Immune checkpoint inhibitor‐mediated psoriasis treated with biologics
by: Pei Ming Yeo, et al.
Published: (2023) -
Acute Kidney Injury Induced by Immune Checkpoint Inhibitors
by: Ruixue Tian, et al.
Published: (2022) -
Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
by: Zou W, et al.
Published: (2021) -
The Strategies and Mechanisms of Immune Checkpoint Inhibitors for Brain Metastases in NSCLC
by: Ji Li, et al.
Published: (2022)